Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers

Overview of attention for article published in Breast Cancer Research, December 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT

Application WO-2023154856-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.